DGK-δ Activators
DGK-δ activators, as listed, include a range of compounds that indirectly influence the activity or regulation of DGK-δ through various cellular mechanisms. This reflects the complexity of lipid signaling pathways and the interconnectivity of DGK-δ with other cellular processes. Compounds like phorbol 12-myristate 13-acetate (PMA) and ceramide are key players in lipid signaling, with PMA acting as a DAG mimic, affecting DGK-δ activity by altering substrate availability. Ceramide, another significant lipid molecule, can modulate DGK-δ activity by influencing the levels of DAG, a direct substrate of DGK-δ.
Other compounds such as lithium chloride and brefeldin A affect DGK-δ indirectly by altering the cellular environment and organelle function. Lithium chloride impacts inositol phosphate metabolism, which is closely linked to DAG levels, while brefeldin A disrupts the Golgi structure, affecting the localization and function of DGK-δ, which is associated with Golgi membranes. Inhibitors of signaling pathways, like U73122 (a PLC inhibitor), D609, wortmannin (a PI3K inhibitor), and rapamycin (an mTOR inhibitor), demonstrate the intricate network in which DGK-δ operates. By modulating the activity of enzymes upstream or parallel to DGK-δ, these compounds can indirectly influence its activity. Staurosporine, as a broad-spectrum kinase inhibitor, further highlights the interplay between different kinases and DGK-δ in cellular signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, a DAG analog, indirectly influences DGK-δ by mimicking DAG's role, potentially altering DGK-δ activity due to substrate competition. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
Ceramide can influence DGK-δ activity indirectly through its role in lipid signaling, possibly impacting DAG levels. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can affect DGK-δ indirectly by modulating inositol phosphate metabolism, potentially influencing DAG levels. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A, by disrupting Golgi structure, may indirectly affect DGK-δ localization and function, as DGK-δ is associated with Golgi membranes. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol, a beta-blocker, can indirectly influence DGK-δ activity through its effects on cellular signaling pathways. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
D609, a phosphatidylcholine-specific PLC inhibitor, may indirectly affect DGK-δ by altering DAG levels in cells. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, may have an indirect effect on DGK-δ signaling pathways, given the broad role of mTOR in cell signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule can indirectly influence DGK-δ activity through its role in the sphingolipid signaling pathway. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP, as a key cellular messenger, may indirectly influence DGK-δ through its broad effects on cellular signaling networks.3 | ||||||